+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adverse Drug Reaction"

Pharmacovigilance and Drug Safety Software Market Report 2025 - Product Thumbnail Image

Pharmacovigilance and Drug Safety Software Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Pharmacovigilance and Drug Safety Software Market 2024 - Product Thumbnail Image

Pharmacovigilance and Drug Safety Software Market 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
From
From
From
Danyelza Patent, Sales & Clinical Trials Outlook 2028 - Product Thumbnail Image

Danyelza Patent, Sales & Clinical Trials Outlook 2028

  • Report
  • October 2021
  • 66 Pages
  • Global
From
From
Unituxin Patent, Sales & Clinical Trials Outlook 2028 - Product Thumbnail Image

Unituxin Patent, Sales & Clinical Trials Outlook 2028

  • Report
  • October 2021
  • 57 Pages
  • Global
From
From
From
From
Pharmacovigilance Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Pharmacovigilance Market - Forecasts from 2024 to 2029

  • Report
  • April 2024
  • 123 Pages
  • Global
From
Loading Indicator

The Adverse Drug Reaction (ADR) market is a subset of the drug discovery industry. It focuses on the identification and evaluation of potential adverse effects of drugs and other substances. ADR research is conducted to ensure the safety of new drugs and to identify potential risks associated with existing drugs. This research is conducted through clinical trials, laboratory studies, and epidemiological studies. ADR research is an important part of the drug discovery process, as it helps to identify potential risks associated with new drugs and to ensure the safety of existing drugs. Companies in the ADR market provide services such as drug safety assessment, risk management, and pharmacovigilance. These services help to identify and evaluate potential adverse effects of drugs and other substances. Companies in the ADR market include Quintiles, Parexel, Covance, ICON, and PPD. Show Less Read more